TianYu Bio-Technology Co., Ltd. (SHA:603717)
China · Delayed Price · Currency is CNY 6.70
+0.16 (2.45%)
Sep 7, 2026, 3:00 PM CST
TianYu Bio-Technology Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 135.31 | 153.39 | 178.05 | 151.6 | 287.73 | 305.66 |
Cash & Short-Term Investments | 135.31 | 153.39 | 178.05 | 151.6 | 287.73 | 305.66 |
Cash Growth | -14.22% | -13.85% | 17.44% | -47.31% | -5.87% | 68.44% |
Accounts Receivable | 458.57 | 402.96 | 735.89 | 893.69 | 1,033 | 1,382 |
Other Receivables | 120 | 299.7 | 258.93 | 307.38 | 294.37 | 296.99 |
Receivables | 578.57 | 702.66 | 994.82 | 1,201 | 1,327 | 1,679 |
Inventory | 227.7 | 224.71 | 223.77 | 159.63 | 239.74 | 105.95 |
Other Current Assets | 219.63 | 45.72 | 56.16 | 115.17 | 59.85 | 132.42 |
Total Current Assets | 1,161 | 1,126 | 1,453 | 1,627 | 1,914 | 2,223 |
Property, Plant & Equipment | 548.17 | 533.42 | 533.56 | 521.79 | 361.86 | 233.26 |
Long-Term Investments | 100.99 | 101.87 | 97.5 | 101.67 | 255.83 | 96.63 |
Goodwill | 1.52 | 1.52 | 2.08 | 5.56 | 5.56 | 5 |
Other Intangible Assets | 24.65 | 25.15 | 26.15 | 7.12 | 7.82 | 104.93 |
Long-Term Accounts Receivable | - | 639.67 | 613.03 | 452.24 | 309.12 | 129.08 |
Long-Term Deferred Tax Assets | 103.67 | 102.05 | 105.4 | 109.43 | 92.12 | 46.83 |
Long-Term Deferred Charges | 8.29 | 5.62 | 4.95 | 5.3 | 4.65 | 3.59 |
Other Long-Term Assets | 907.15 | 258.49 | 279.51 | 342.06 | 409.89 | 486.69 |
Total Assets | 2,856 | 2,893 | 3,215 | 3,273 | 3,461 | 3,329 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 661.58 | 683.15 | 638.33 | 684 | 666.01 | 684.18 |
Accrued Expenses | 41.14 | 31.08 | 28.24 | 19.38 | 16.59 | 6.62 |
Short-Term Debt | 91.09 | 164.07 | 128.23 | 168.35 | 152.76 | 216.34 |
Current Portion of Long-Term Debt | 184.34 | 93.73 | 115.51 | 77.61 | 39.39 | 311.02 |
Current Portion of Leases | - | 13.32 | 35.94 | 25.94 | 33.71 | 6.31 |
Current Income Taxes Payable | 2.46 | 2.62 | 0.05 | - | 1.35 | 2.28 |
Current Unearned Revenue | 81.48 | 79.15 | 144.65 | 82.5 | 71.63 | 80.07 |
Other Current Liabilities | 229.31 | 258.51 | 255.4 | 180.37 | 149.4 | 117.15 |
Total Current Liabilities | 1,291 | 1,326 | 1,346 | 1,238 | 1,131 | 1,424 |
Long-Term Debt | 688.76 | 692.14 | 753.37 | 751.37 | 649.16 | 212.11 |
Long-Term Leases | 84.54 | 144.89 | 247.13 | 281.18 | 209.79 | 41 |
Long-Term Unearned Revenue | 0.57 | 0.61 | 0.69 | - | - | - |
Long-Term Deferred Tax Liabilities | 2.34 | 2.45 | 2.68 | 0.07 | 0.26 | 0.58 |
Other Long-Term Liabilities | 245.11 | 133.77 | 156.24 | 167.5 | 36.79 | 39.59 |
Total Liabilities | 2,313 | 2,299 | 2,506 | 2,438 | 2,027 | 1,717 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 290.15 | 290.15 | 290.15 | 290.15 | 290.15 | 290.15 |
Additional Paid-In Capital | 893.59 | 912.8 | 912.21 | 931.77 | 931.9 | 930.16 |
Retained Earnings | -844.9 | -790.52 | -683.62 | -576.26 | -81.85 | 197.55 |
Total Common Equity | 338.83 | 412.42 | 518.74 | 645.66 | 1,140 | 1,418 |
Minority Interest | 204.11 | 181.22 | 189.79 | 188.69 | 293.53 | 193.73 |
Shareholders' Equity | 542.94 | 593.64 | 708.53 | 834.35 | 1,434 | 1,612 |
Total Liabilities & Equity | 2,856 | 2,893 | 3,215 | 3,273 | 3,461 | 3,329 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,049 | 1,108 | 1,280 | 1,304 | 1,085 | 786.78 |
Net Cash (Debt) | -913.42 | -954.76 | -1,102 | -1,153 | -797.09 | -481.12 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -3.15 | -3.29 | -3.80 | -3.97 | -3.30 | -1.81 |
Filing Date Shares Outstanding | 290.55 | 290.15 | 290.15 | 290.15 | 290.15 | 290.15 |
Total Common Shares Outstanding | 290.55 | 290.15 | 290.15 | 290.15 | 290.15 | 290.15 |
Working Capital | -130.18 | -199.15 | 106.45 | 389.31 | 783.56 | 798.86 |
Book Value Per Share | 1.17 | 1.42 | 1.79 | 2.23 | 3.93 | 4.89 |
Tangible Book Value | 312.66 | 385.76 | 490.5 | 632.98 | 1,127 | 1,308 |
Tangible Book Value Per Share | 1.08 | 1.33 | 1.69 | 2.18 | 3.88 | 4.51 |
Buildings | - | 158.14 | 150.56 | 98.24 | 7.96 | 176.46 |
Machinery | - | 275.01 | 245.82 | 209.27 | 88.56 | 31.86 |
Construction In Progress | - | 35.66 | 21.37 | 19.06 | 7.37 | 3.93 |